Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Axsome
Pharma
Axsome will begin trial this year in MDD with daytime sleepiness
After reporting a successful trial of Sunosi in patients with ADHD, Axsome has unveiled mixed results for Sunosi in a study in patients with MDD.
Kevin Dunleavy
Apr 1, 2025 4:40pm
Axsome's Sunosi scores in phase 3 ADHD trial
Mar 25, 2025 11:46am
Teva agrees with Axsome to keep generic off market until 2038
Feb 10, 2025 11:28am
Axsome secures hard-fought FDA nod for migraine drug Symbravo
Jan 31, 2025 8:18am
After trial win, Axsome eyes FDA filing for narcolepsy hopeful
Nov 27, 2024 9:46am
Axsome to add nearly 100 Auvelity sales reps to workforce
Nov 6, 2023 12:05pm
